메뉴 건너뛰기




Volumn 18, Issue 3, 2004, Pages 703-713

Nonmyeloablative stem cell transplantation for chronic myeloid leukemia

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; FLUDARABINE; IDARUBICIN; MELPHALAN; THIOTEPA; THYMOCYTE ANTIBODY;

EID: 3242766830     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2004.03.009     Document Type: Review
Times cited : (6)

References (36)
  • 1
    • 0003224009 scopus 로고
    • A minute chromosome (Phl) in human chronic granulocytic leukemia
    • Nowell P.C. A minute chromosome (Phl) in human chronic granulocytic leukemia. Blut. 8:1962;65-66
    • (1962) Blut , vol.8 , pp. 65-66
    • Nowell, P.C.1
  • 2
    • 0015694748 scopus 로고
    • A new consistent chromosomal abnormality in chronic myeloid leukemia identified by quinacrine fluorescence and Giemsa staining [letter]
    • Rowley J.D. A new consistent chromosomal abnormality in chronic myeloid leukemia identified by quinacrine fluorescence and Giemsa staining [letter]. Nature. 243:1973;290-293
    • (1973) Nature , vol.243 , pp. 290-293
    • Rowley, J.D.1
  • 3
    • 0025854383 scopus 로고
    • Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients
    • Talpaz M., Kantarjian H., Kurzrock R., et al. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients. Ann Intern Med. 114:1991;532-538
    • (1991) Ann Intern Med , vol.114 , pp. 532-538
    • Talpaz, M.1    Kantarjian, H.2    Kurzrock, R.3
  • 4
    • 0035810147 scopus 로고    scopus 로고
    • Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
    • Druker B.J., Talpaz M., Resta D.J., et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 344:2001;1031-1037
    • (2001) N Engl J Med , vol.344 , pp. 1031-1037
    • Druker, B.J.1    Talpaz, M.2    Resta, D.J.3
  • 5
    • 0029952614 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplantation for CML: A report from the International Bone Marrow Registry
    • Horowitz M.M., Rowlings P.A., Passweg J.R. Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Registry. Bone Marrow Transplant. 17:1996;S5-S6
    • (1996) Bone Marrow Transplant , vol.17 , pp. 5-S6
    • Horowitz, M.M.1    Rowlings, P.A.2    Passweg, J.R.3
  • 6
    • 0027519484 scopus 로고
    • Bone marrow transplantation for chronic myeloid leukemia: Long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation
    • Gratwohl A., Hermans J., Niederwieser D., et al. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant. 12:1993;509-516
    • (1993) Bone Marrow Transplant , vol.12 , pp. 509-516
    • Gratwohl, A.1    Hermans, J.2    Niederwieser, D.3
  • 7
    • 0030003140 scopus 로고    scopus 로고
    • Marrow transplantation for CML: The Seattle experience
    • Clift R.A., Storb R. Marrow transplantation for CML: the Seattle experience. Bone Marrow Transplant. 17:1996;S1-S3
    • (1996) Bone Marrow Transplant , vol.17 , pp. 1-S3
    • Clift, R.A.1    Storb, R.2
  • 8
    • 0027504087 scopus 로고
    • Graft-versus-leukemia: No longer an epiphenomenon
    • Antin J.H. Graft-versus-leukemia: no longer an epiphenomenon. Blood. 82:1993;2273-2277
    • (1993) Blood , vol.82 , pp. 2273-2277
    • Antin, J.H.1
  • 9
    • 0019861205 scopus 로고
    • Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation
    • Weiden P.L., Sullivan K.M., Flournoy N., et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med. 304:1981;1529-1533
    • (1981) N Engl J Med , vol.304 , pp. 1529-1533
    • Weiden, P.L.1    Sullivan, K.M.2    Flournoy, N.3
  • 10
    • 0023690307 scopus 로고
    • Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion
    • Goldman J.M., Gale R.P., Horowitz M.M., et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med. 108:1988;806-814
    • (1988) Ann Intern Med , vol.108 , pp. 806-814
    • Goldman, J.M.1    Gale, R.P.2    Horowitz, M.M.3
  • 11
    • 0027437385 scopus 로고
    • Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: Efficacy and toxicity of a defined T-cell dose
    • Drobyski W.R., Keever C.A., Roth M.S., et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood. 82:1993;2310-2318
    • (1993) Blood , vol.82 , pp. 2310-2318
    • Drobyski, W.R.1    Keever, C.A.2    Roth, M.S.3
  • 12
    • 0028237517 scopus 로고
    • Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse
    • van Rhee F., Lin F., Cullis J.O., et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood. 83:1994;3377-3383
    • (1994) Blood , vol.83 , pp. 3377-3383
    • Van Rhee, F.1    Lin, F.2    Cullis, J.O.3
  • 13
    • 0025678601 scopus 로고
    • Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
    • Kolb H.J., Mittermuller J., Clemm C., et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 76:1990;2462-2465
    • (1990) Blood , vol.76 , pp. 2462-2465
    • Kolb, H.J.1    Mittermuller, J.2    Clemm, C.3
  • 14
    • 0029618806 scopus 로고
    • Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes
    • Slavin S., Naparstek E., Nagler A., et al. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. Exp Hematol. 23:1995;1553-1562
    • (1995) Exp Hematol , vol.23 , pp. 1553-1562
    • Slavin, S.1    Naparstek, E.2    Nagler, A.3
  • 15
    • 0028871935 scopus 로고
    • CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation
    • Giralt S., Hester J., Huh Y., et al. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood. 86:1995;4337-4343
    • (1995) Blood , vol.86 , pp. 4337-4343
    • Giralt, S.1    Hester, J.2    Huh, Y.3
  • 16
    • 0017166432 scopus 로고
    • Long term survival of skin allografts in mice treated with fractionated total lymphoid irradiation
    • Slavin S., Strober S., Fuks Z., et al. Long term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science. 193:1976;1252-1254
    • (1976) Science , vol.193 , pp. 1252-1254
    • Slavin, S.1    Strober, S.2    Fuks, Z.3
  • 17
    • 0028858133 scopus 로고
    • DLA-identical bone marrow grafts after low-dose total body irradiation: Effects of high-dose corticosteroids and cyclosporine on engraftment
    • Yu C., Storb R., Mathey B., et al. DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment. Blood. 86:1995;4376-4381
    • (1995) Blood , vol.86 , pp. 4376-4381
    • Yu, C.1    Storb, R.2    Mathey, B.3
  • 18
    • 0034657267 scopus 로고    scopus 로고
    • Adoptive immunotherapy in canine mixed chimeras after non-myeloablative hematopoietic cell transplantation
    • Georges G.E., Storb R., Thompson J.D., et al. Adoptive immunotherapy in canine mixed chimeras after non-myeloablative hematopoietic cell transplantation. Blood. 95:2000;3262-3269
    • (2000) Blood , vol.95 , pp. 3262-3269
    • Georges, G.E.1    Storb, R.2    Thompson, J.D.3
  • 20
    • 0030925301 scopus 로고    scopus 로고
    • Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
    • Giralt S., Estey E., Albitar M., et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood. 89:1997;4531-4536
    • (1997) Blood , vol.89 , pp. 4531-4536
    • Giralt, S.1    Estey, E.2    Albitar, M.3
  • 21
    • 0000271327 scopus 로고    scopus 로고
    • Comparisons of donor chimerism, graft rejection, and GVHD after hematopoietic stem cell transplants (HSCT) from HLA matched siblings and unrelated donors using conditioning with 2 Gy TBI with and without fludarabine [abstract]
    • Maris M.B., Sandmeier B.M., Niederwieser D., et al. Comparisons of donor chimerism, graft rejection, and GVHD after hematopoietic stem cell transplants (HSCT) from HLA matched siblings and unrelated donors using conditioning with 2 Gy TBI with and without fludarabine [abstract]. Blood. 96(1):2000;520a
    • (2000) Blood , vol.96 , Issue.1
    • Maris, M.B.1    Sandmeier, B.M.2    Niederwieser, D.3
  • 22
    • 0033642531 scopus 로고    scopus 로고
    • Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
    • Spitzer T.R., McAfee S., Sackstein R., et al. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant. 6(3A):2000;309-320
    • (2000) Biol Blood Marrow Transplant , vol.6 , Issue.3 A , pp. 309-320
    • Spitzer, T.R.1    McAfee, S.2    Sackstein, R.3
  • 23
    • 12244280160 scopus 로고    scopus 로고
    • FLAG-IDA, a non-ablative preparative regimen, with allogeneic PBSC transplantation for CML [abstract]
    • Champlin R.E., Shimoni A., Cohen A., et al. FLAG-IDA, a non-ablative preparative regimen, with allogeneic PBSC transplantation for CML [abstract]. Blood. 96(Suppl 1):2000;410a
    • (2000) Blood , vol.96 , Issue.SUPPL. 1
    • Champlin, R.E.1    Shimoni, A.2    Cohen, A.3
  • 24
    • 0035254219 scopus 로고    scopus 로고
    • Melphalan and purine analog-containing preparative regimens: Reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
    • Giralt S., Thall P.F., Khouri I., et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood. 97:2001;631-637
    • (2001) Blood , vol.97 , pp. 631-637
    • Giralt, S.1    Thall, P.F.2    Khouri, I.3
  • 25
    • 0037438397 scopus 로고    scopus 로고
    • Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase
    • Or R., Shapira M.Y., Resnick I., et al. Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood. 101(2):2003;441-445
    • (2003) Blood , vol.101 , Issue.2 , pp. 441-445
    • Or, R.1    Shapira, M.Y.2    Resnick, I.3
  • 26
    • 85112360893 scopus 로고    scopus 로고
    • Induction of molecular remissions in CML with non-myeloablative HLA-identical sibling allografts [abstract]
    • Sandmaier B.M., Niederwieser D., McSweeney P.A., et al. Induction of molecular remissions in CML with non-myeloablative HLA-identical sibling allografts [abstract]. Blood. 96(Suppl 1):2000;201a
    • (2000) Blood , vol.96 , Issue.SUPPL. 1
    • Sandmaier, B.M.1    Niederwieser, D.2    McSweeney, P.A.3
  • 27
    • 0003277746 scopus 로고    scopus 로고
    • Non-myeloablative peripheral blood stem cell transplantation for chronic myelogenous leukemia
    • Sloand E.M., Childs R.W., Greene A., et al. Non-myeloablative peripheral blood stem cell transplantation for chronic myelogenous leukemia. [abstract]. Blood. 96(Suppl 1):2000;783a
    • (2000) Blood , vol.96 , Issue.SUPPL. 1
    • Sloand, E.M.1    Childs, R.W.2    Greene, A.3
  • 28
    • 0034772639 scopus 로고    scopus 로고
    • Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: A retrospective analysis
    • Bornhauser M., Kiehl M., Siegert W., et al. Cooperative German Transplant Study Group Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis. Br J Haematol. 115(1):2001;119-124
    • (2001) Br J Haematol , vol.115 , Issue.1 , pp. 119-124
    • Bornhauser, M.1    Kiehl, M.2    Et Al., S.W.3
  • 29
    • 12244289841 scopus 로고    scopus 로고
    • Favorable outcome of non-myeloablative stem cell transplant for CML in first chronic phase; A retrospective study of the European Group for Blood and Marrow Transplantation (EBMT) [abstract]
    • Lalancette M., Rezvani K., Szydlo R., et al. Favorable outcome of non-myeloablative stem cell transplant for CML in first chronic phase; a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT) [abstract]. Blood. 96(Suppl 1):2000;2340a
    • (2000) Blood , vol.96 , Issue.SUPPL. 1
    • Lalancette, M.1    Rezvani, K.2    Szydlo, R.3
  • 30
    • 0025963233 scopus 로고
    • Graft-versus-host disease
    • Ferrara J.L., Deeg H.J. Graft-versus-host disease. N Engl J Med. 324:1991;667-674
    • (1991) N Engl J Med , vol.324 , pp. 667-674
    • Ferrara, J.L.1    Deeg, H.J.2
  • 31
    • 0030817818 scopus 로고    scopus 로고
    • Transfusion-associated graft-versus-host disease
    • Orlin J.B., Ellis M.H. Transfusion-associated graft-versus-host disease. Curr Opin Hemato. 14:1997;442-448
    • (1997) Curr Opin Hemato , vol.14 , pp. 442-448
    • Orlin, J.B.1    Ellis, M.H.2
  • 32
    • 4244017667 scopus 로고    scopus 로고
    • Graft versus host disease after non-myeloablative versus myeloablative conditioning regimens in fully matched sibling donor hematopoietic stem cell transplants [abstract]
    • Couriel D., Giralt S., de Lima M., et al. Graft versus host disease after non-myeloablative versus myeloablative conditioning regimens in fully matched sibling donor hematopoietic stem cell transplants [abstract]. Blood. 96(Suppl 1):2000;408a
    • (2000) Blood , vol.96 , Issue.SUPPL. 1
    • Couriel, D.1    Giralt, S.2    De Lima, M.3
  • 33
    • 0000271328 scopus 로고    scopus 로고
    • Older patient age remains a risk factor for transplant related mortality following nonmyeloablative allogeneic stem cell transplantation [abstract]
    • Childs R.W., Bahceci E., Eniafe R., et al. Older patient age remains a risk factor for transplant related mortality following nonmyeloablative allogeneic stem cell transplantation [abstract]. Blood. 96(Suppl 1):2000;520a
    • (2000) Blood , vol.96 , Issue.SUPPL. 1
    • Childs, R.W.1    Bahceci, E.2    Eniafe, R.3
  • 34
    • 85047690151 scopus 로고
    • Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia
    • Storb R., Prentice R.L., Thomas E.D., et al. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Br J Haematol. 55:1983;573-585
    • (1983) Br J Haematol , vol.55 , pp. 573-585
    • Storb, R.1    Prentice, R.L.2    Thomas, E.D.3
  • 35
    • 0002042474 scopus 로고    scopus 로고
    • Non-myeloablative stem cell transplantation: Lessons from the first generation trials
    • Giralt S. Non-myeloablative stem cell transplantation: lessons from the first generation trials. Leuk Lymphoma Updates. 2:1999;4-7
    • (1999) Leuk Lymphoma Updates , vol.2 , pp. 4-7
    • Giralt, S.1
  • 36
    • 0025852066 scopus 로고
    • Are new conditioning regimens for transplants in acute myelogenous leukemia better?
    • Aurer I., Gale R.P. Are new conditioning regimens for transplants in acute myelogenous leukemia better? Bone Marrow Transplant. 7:1991;255-261
    • (1991) Bone Marrow Transplant , vol.7 , pp. 255-261
    • Aurer, I.1    Gale, R.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.